Sessions

Opening Plenary Debate: The Cost on a Cure – Do The Results Justify The Price
Opening Plenary Panel: Thriving or Surviving – An Analysis of the Advanced Therapies Landscape Within Europe & What the Future Holds

Opening Plenary Debate: The Cost on a Cure – Do The Results Justify The Price

06 Sep 2023
09:45
Auditorium
SPONSORED BY
Dark Horse Consulting Group

Panel Participants: 

Moderated by: Anthony Davies, Founder & Chief Executive Officer, Dark Horse Consulting Group  

  • Katrien Reynders, Board Member, HollandBIO
  • Lucy Ellerker-Jones, Founder, Opie Jones Foundation  
  • Alexander Natz, Secretary General, European Confederation of Pharmaceutical Entrepreneurs (EUCOPE)
  • Joshi Venugopal, General Manager, Head of Europe for Gene Therapies and Rare Diseases, Novartis Gene Therapies  

Speakers

Anthony Davies
Founder & Chief Executive Officer
Dark Horse Consulting Group
Katrien Reynders
Board Member
Holland BIO
Alexander Natz
Secretary General
European Confederation of Pharmaceutical Entrepreneurs (EUCOPE)
Joshi Venugopal
General Manager, Head of Europe for Gene Therapies and Rare Diseases
Novartis Gene Therapies